US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

Articles published by MacroGenics, Inc.

News headline image
MacroGenics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Announces Achievement of $10 Million Milestone Following Gilead’s Exercise of Option to License Preclinical Bispecific Program
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Participate in the Stifel 2025 Healthcare Conference
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Appoints Eric Risser as President and Chief Executive Officer
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics and Sagard Healthcare Partners Enter into ZYNYZ® Royalty Purchase Agreement
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference 2025
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Announces Date of First Quarter 2025 Financial Results
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Participate in Upcoming Investor Conference
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Announces Date of Fourth Quarter and Full Year 2024 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Participate in Upcoming Investor Conference
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Announces Leadership Transition
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Announces Date of Third Quarter 2024 Financial Results Conference Call
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Provides Vobramitamab Duocarmazine Update
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics Announces Achievement of $100 Million in Milestones Related to Retifanlimab Collaboration with Incyte
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Participate in Upcoming Investor Conference
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX
News headline image
MacroGenics to Participate in Upcoming Investor Conferences
From MacroGenics, Inc.
Via GlobeNewswire
Tickers MGNX